SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

PURPOSE: The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or gallbladder carcinoma (GBCA) is unknown. S0809 was designed to estimate 2-year survival (overall and after R0 or R1 resection), pattern of relapse, and toxicity in patients treated with this adjuvant regimen. PAT...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Ben-Josef, Edgar, Guthrie, Katherine A., El-Khoueiry, Anthony B., Corless, Christopher L., Zalupski, Mark M., Lowy, Andrew M., Thomas, Charles R., Alberts, Steven R., Dawson, Laura A., Micetich, Kenneth C., Thomas, Melanie B., Siegel, Abby B., Blanke, Charles D.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534524/
https://ncbi.nlm.nih.gov/pubmed/25964250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.60.2219
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares